About this product

Dosage and Administration
Adults (including the elderly): One drop to be instilled into the eye, or as required. Each Minims Atropine Eye Drops unit
should be discarded after a single use.

Contraindications
Minims Atropine Eye Drops are contraindicated in patients with hypersensitivity to any of the components of the
preparation. Minims Atropine Eye Drops are contraindicated in the presence of angle closure glaucoma or where angle
closure glaucoma is suspected.

Precautions
For topical ophthalmic use only. Not for injection. Atropine eye drops are not recommended in infants aged less than 3
months. Atropine eye drops should be used with caution in children, in elderly patients and when the ambient
temperature is high. Atropine eye drops should not be used in cases of confirmed narrow-angle glaucoma or where
latent narrow angle glaucoma is suspected. Atropine eye drops should not be used in cases of keratoconus or synechiae
between the iris and lens, unless the clinical benefit outweighs the risk.

Interactions
Anticholinergics, antiglaucoma agents, antimyasthenics, potassium citrate, potassium supplements, carbachol,
physostigmine, pilocarpine and central nervous system depression producing medications.

Pregnancy & Lactation
Atropine sulphate may be systemically absorbed after ocular administration; however, significant effects on the foetus
have not been reported. Nevertheless, caution is advised. Systemically absorbed atropine sulphate is distributed into
breast milk in very small amounts. It may cause adverse effects, such as rapid pulse, fever, or dry skin, in breastfeeding
infants of mothers using ophthalmic atropine.

Ability to Drive & Use Machines
Minims Atropine Eye Drops may cause transient blurring of vision on instillation. Patients should be advised not to drive
or operate hazardous machinery until vision is clear.

Adverse Effects
Local adverse effects include blurred vision, local irritation, allergic conjunctivitis or blepharoconjunctivitis, contact
dermatitis, eczematous dermatitis, increased intraocular pressure and precipitation of narrow angle glaucoma. Systemic
reactions may occur after ocular instillation, particularly in children or elderly patients. Symptoms of systemic toxicity
include dryness of the mouth and skin, flushing, fever, rash, thirst, tachycardia, irritability, hyperactivity, ataxia, confusion,
somnolence, hallucinations and delirium.

Storage
Store at 2°C to 8°C. Protect from light.